Your browser doesn't support javascript.
loading
Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.
Murugan, Rajagopal; Scally, Stephen W; Costa, Giulia; Mustafa, Ghulam; Thai, Elaine; Decker, Tizian; Bosch, Alexandre; Prieto, Katherine; Levashina, Elena A; Julien, Jean-Philippe; Wardemann, Hedda.
  • Murugan R; B Cell Immunology, German Cancer Research Institute (DKFZ), Heidelberg, Germany.
  • Scally SW; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
  • Costa G; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Mustafa G; Vector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany.
  • Thai E; B Cell Immunology, German Cancer Research Institute (DKFZ), Heidelberg, Germany.
  • Decker T; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
  • Bosch A; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
  • Prieto K; B Cell Immunology, German Cancer Research Institute (DKFZ), Heidelberg, Germany.
  • Levashina EA; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
  • Julien JP; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
  • Wardemann H; Vector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany. levashina@mpiib-berlin.mpg.de.
Nat Med ; 26(7): 1135-1145, 2020 07.
Article en En | MEDLINE | ID: mdl-32451496
The circumsporozoite protein of the human malaria parasite Plasmodium falciparum (PfCSP) is the main target of antibodies that prevent the infection and disease, as shown in animal models. However, the limited efficacy of the PfCSP-based vaccine RTS,S calls for a better understanding of the mechanisms driving the development of the most potent human PfCSP antibodies and identification of their target epitopes. By characterizing 200 human monoclonal PfCSP antibodies induced by sporozoite immunization, we establish that the most potent antibodies bind around a conserved (N/D)PNANPN(V/A) core. High antibody affinity to the core correlates with protection from parasitemia in mice and evolves around the recognition of NANP motifs. The data suggest that the rational design of a next-generation PfCSP vaccine that elicits high-affinity antibody responses against the core epitope will promote the induction of protective humoral immune responses.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium falciparum / Anticuerpos Antiprotozoarios / Malaria Falciparum / Vacunas contra la Malaria Límite: Animals / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium falciparum / Anticuerpos Antiprotozoarios / Malaria Falciparum / Vacunas contra la Malaria Límite: Animals / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article